By Manas Mishra and Michael Erman May 17 (Reuters) – The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a[Read More…]